These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 11832771)

  • 21. Chromosome 9 deletions and recurrence of superficial bladder cancer: identification of four regions of prognostic interest.
    Simoneau M; LaRue H; Aboulkassim TO; Meyer F; Moore L; Fradet Y
    Oncogene; 2000 Dec; 19(54):6317-23. PubMed ID: 11175346
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Microsatellite allelotyping of chinese nasopharyngeal carcinomas.
    Lung ML; Choi CV; Kong H; Yuen PW; Kwong D; Sham J; Wei WI
    Anticancer Res; 2001; 21(4B):3081-4. PubMed ID: 11712814
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Loss of heterozygosity on the long arm of human chromosome 7 in sporadic renal cell carcinomas.
    Shridhar V; Sun QC; Miller OJ; Kalemkerian GP; Petros J; Smith DI
    Oncogene; 1997 Nov; 15(22):2727-33. PubMed ID: 9400999
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Positive correlation between allelic loss at chromosome 14q24-31 and poor prognosis of patients with renal cell carcinoma.
    Kaku H; Ito S; Ebara S; Ouchida M; Nasu Y; Tsushima T; Kumon H; Shimizu K
    Urology; 2004 Jul; 64(1):176-81. PubMed ID: 15245966
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumour suppressor gene (CDKNA2) status on chromosome 9p in resected renal tissue improves prognosis of localised kidney cancer.
    El-Mokadem I; Kidd T; Pratt N; Fleming S; Nabi G
    Oncotarget; 2016 Nov; 7(45):73045-73054. PubMed ID: 27682877
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Loss of heterozygosity in the 9p21 region as an inactivation mechanism of the p16 suppressor gene].
    Maestro de las Casas ML; Sanz-Casla MT; del Barco V; Moreno J; Zanna I; Redondo E; Fernández C; Izquierdo L; Resel Estévez L
    Arch Esp Urol; 2000 Sep; 53(7):603-9. PubMed ID: 11037653
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Loss of heterozygosity for chromosomes 1p and 16q is an adverse prognostic factor in favorable-histology Wilms tumor: a report from the National Wilms Tumor Study Group.
    Grundy PE; Breslow NE; Li S; Perlman E; Beckwith JB; Ritchey ML; Shamberger RC; Haase GM; D'Angio GJ; Donaldson M; Coppes MJ; Malogolowkin M; Shearer P; Thomas PR; Macklis R; Tomlinson G; Huff V; Green DM;
    J Clin Oncol; 2005 Oct; 23(29):7312-21. PubMed ID: 16129848
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Loss of heterozygosity in laryngeal cancer.
    Rogowski M; Walenczak I; Pepiński W; Skawrońska M; Sieśkiewicz A; Klatka J
    Rocz Akad Med Bialymst; 2004; 49():262-4. PubMed ID: 15631354
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High-density allelotyping of chromosome 8p in hepatocellular carcinoma and clinicopathologic correlation.
    Chan KL; Lee JM; Guan XY; Fan ST; Ng IO
    Cancer; 2002 Jun; 94(12):3179-85. PubMed ID: 12115350
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clonal divergence and genetic heterogeneity in clear cell renal cell carcinomas with sarcomatoid transformation.
    Jones TD; Eble JN; Wang M; Maclennan GT; Jain S; Cheng L
    Cancer; 2005 Sep; 104(6):1195-203. PubMed ID: 16047350
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chromosome 9p deletions identify an aggressive phenotype of clear cell renal cell carcinoma.
    La Rochelle J; Klatte T; Dastane A; Rao N; Seligson D; Said J; Shuch B; Zomorodian N; Kabbinavar F; Belldegrun A; Pantuck AJ
    Cancer; 2010 Oct; 116(20):4696-702. PubMed ID: 20629029
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Loss of heterozygosity on chromosome 6p21.2 as a potential marker for recurrence after radiotherapy of human cervical cancer.
    Harima Y; Harima K; Sawada S; Tanaka Y; Arita S; Ohnishi T
    Clin Cancer Res; 2000 Mar; 6(3):1079-85. PubMed ID: 10741737
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lack of genetic changes at specific genomic sites separates renal oncocytomas from renal cell carcinomas.
    Herbers J; Schullerus D; Chudek J; Bugert P; Kanamaru H; Zeisler J; Ljungberg B; Akhtar M; Kovacs G
    J Pathol; 1998 Jan; 184(1):58-62. PubMed ID: 9582528
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Frequent loss of heterozygosity and three critical regions on the short arm of chromosome 8 in ovarian adenocarcinomas.
    Wright K; Wilson PJ; Kerr J; Do K; Hurst T; Khoo SK; Ward B; Chenevix-Trench G
    Oncogene; 1998 Sep; 17(9):1185-8. PubMed ID: 9764830
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Detailed mapping and clinical significance of loss of heterozygosity on 9p13-23 in laryngeal squamous cell carcinoma by microsatellite analysis].
    Xu XF; Tang PZ; Cheng SJ
    Ai Zheng; 2003 May; 22(5):452-7. PubMed ID: 12753701
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Loss of P16 expression and chromosome 9p21 LOH in predicting outcome of patients affected by superficial bladder cancer.
    Bartoletti R; Cai T; Nesi G; Roberta Girardi L; Baroni G; Dal Canto M
    J Surg Res; 2007 Dec; 143(2):422-7. PubMed ID: 17612565
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Renal cell carcinoma of end-stage renal disease: an analysis of chromosome 3, 7, and 17 abnormalities by microsatellite amplification.
    Hughson MD; Bigler S; Dickman K; Kovacs G
    Mod Pathol; 1999 Mar; 12(3):301-9. PubMed ID: 10102616
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Allelotype of endometrial carcinoma.
    Fujino T; Risinger JI; Collins NK; Liu FS; Nishii H; Takahashi H; Westphal EM; Barrett JC; Sasaki H; Kohler MF
    Cancer Res; 1994 Aug; 54(16):4294-8. PubMed ID: 8044774
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Allelotype of human bladder cancer.
    Knowles MA; Elder PA; Williamson M; Cairns JP; Shaw ME; Law MG
    Cancer Res; 1994 Jan; 54(2):531-8. PubMed ID: 8275491
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Distal nephron renal tumors: microsatellite allelotype.
    Polascik TJ; Cairns P; Epstein JI; Fuzesi L; Ro JY; Marshall FF; Sidransky D; Schoenberg M
    Cancer Res; 1996 Apr; 56(8):1892-5. PubMed ID: 8620510
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.